DRUG DISCOVERY BOOTCAMP WORKSHOP
Join members of the Novartis Institutes for BioMedical Research training team for a hands on class in how to make a drug. This focused bootcamp will provide you the tools to learn how industry experts design and manufacture the drugs of tomorrow. The phases of drug development including discovery, pre-clinical research and clinical testing will be discussed with a focus on the common roles that postdoctoral scholars can pursue in industry. Speakers will include NIBR experts in training scientists for careers in industry R&D. Space is limited to two sections of 36 participants each. Note: this workshop requires special registration and incurs an additional fee of $5 during registration.
ASSOCIATE DIRECTOR OF THE SCIENTIFIC & TEAM EXCELLENCE PROGRAM OFFICE AT NOVARTIS INSTITUTES OF BIOMEDICAL RESEARCH
Alokesh has expertise ranging from discovery through development phase for small molecules and biologics and broad knowledge of pharmacology in areas ranging from diabetes/metabolic diseases, obesity to CNS disorders, incretin biology, pancreatic beta cell function, analgesia and behavioral pharmacology. He has authored 36 published papers and 3 book chapters.
RESEARCH FELLOW IN TOXICOLOGY/TRANSLATIONAL SCIENCES AT NOVARTIS INSTITUTES OF BIOMEDICAL RESEARCH
Sanjeev Thohan is a highly motivated research scientist who with every move has sought new challenges to overcome with each career-based move. He holds MS and PhD degrees in Pharmacology and Toxicology with concentrations in drug metabolism mechanisms, bioactivation pathways, and systems toxicology. He has actively contributed to: preparation of Pre-IND/IND and proof of concept documentation to support regulatory filings as preclinical development continues; inter-species scaling and projection of FIM dosage algorithm development; metabolic pathway elucidation and structural (SAR) feedback to medicinal chemistry for additional iterations based on biological data streams; high throughput bioanalytical method development/transfer, as well as troubleshooting for rapid method development/implementation. He has also led teams for evaluation of strategic critical pathway development, implementation and execution to provide data frontloading and reduction in time to IND. He is a highly motivated research scientist who has worked at Walter Reed Army Institute for Research, Covance Laboratories, AstraZeneca, Viropharma, Exelixis and as the founder of SARx Consulting and it currently at Novartis in Cambridge, MA. Sanjeev’s track record includes advancement of 27 small molecule compounds through discovery to IND and various stages of active clinical development since 1997. Therapeutic areas in which he has been actively involved are oncology, cardiovascular, metabolic diseases and antimicrobial, as well as antiviral therapeutic areas.